Company Valuation: Thermo Fisher Scientific, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 262,925 216,998 205,083 198,988 217,704 166,416 - -
Change - -17.47% -5.49% -2.97% 9.41% -23.56% - -
Enterprise Value (EV) 1 293,318 242,962 231,923 226,254 247,237 197,304 192,412 186,732
Change - -17.17% -4.54% -2.44% 9.27% -20.2% -2.48% -2.95%
P/E ratio 34.3x 31.2x 34.4x 31.5x 32.7x 22.3x 19.4x 16.5x
PBR 6.45x 4.89x 4.39x 4x - 2.99x 2.71x 2.44x
PEG - -3.32x -2.8x 4.51x 4.47x 1.7x 1.3x 0.9x
Capitalization / Revenue 6.71x 4.83x 4.79x 4.64x 4.89x 3.48x 3.3x 3.11x
EV / Revenue 7.48x 5.41x 5.41x 5.28x 5.55x 4.13x 3.82x 3.49x
EV / EBITDA 22.6x 20.3x 21.3x 20.8x 22.2x 15.9x 14.4x 12.9x
EV / EBIT 24.2x 22.1x 23.6x 23.3x 24.5x 17.7x 16x 14.4x
EV / FCF 41.8x 35x 33.5x 30.9x 39.3x 27.6x 21.5x 19.7x
FCF Yield 2.39% 2.85% 2.99% 3.24% 2.55% 3.62% 4.64% 5.08%
Dividend per Share 2 1.04 1.2 1.4 1.56 - 1.843 1.939 2.08
Rate of return 0.16% 0.22% 0.26% 0.3% - 0.41% 0.43% 0.46%
EPS 2 19.46 17.63 15.45 16.53 17.74 20.11 23.13 27.16
Distribution rate 5.34% 6.81% 9.06% 9.44% - 9.16% 8.38% 7.66%
Net sales 1 39,211 44,915 42,857 42,879 44,556 47,776 50,376 53,503
EBITDA 1 12,969 11,971 10,878 10,863 11,159 12,399 13,351 14,483
EBIT 1 12,138 10,985 9,810 9,707 10,109 11,153 12,004 12,980
Net income 1 7,725 6,950 5,995 6,335 6,704 7,337 8,192 9,172
Net Debt 1 30,393 25,964 26,840 27,266 29,533 30,888 25,996 20,317
Reference price 2 667.24 550.69 530.79 520.23 579.45 447.81 447.81 447.81
Nbr of stocks (in thousands) 394,048 394,048 386,372 382,500 375,708 371,621 - -
Announcement Date 02/02/22 01/02/23 31/01/24 30/01/25 29/01/26 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
22.27x4.13x15.91x0.41% 166B
48.49x12.71x28.48x-.--% 156B
26.49x5x15.58x0.9% 118B
20.96x4.18x13.67x-.--% 84.44B
29.3x6.52x20.64x-.--% 47.31B
17.84x2.07x10.57x2.94% 43.8B
35.59x5.73x17.46x-.--% 32.72B
21.2x4.35x15.08x0.92% 31.25B
19.61x5.17x13.01x1.17% 30.14B
13.66x1.55x8.66x0.25% 28.01B
Average 25.54x 5.14x 15.91x 0.66% 73.87B
Weighted average by Cap. 28.64x 6.15x 17.89x 0.51%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. TMO Stock
  4. Valuation Thermo Fisher Scientific, Inc.